calendar
236 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
236 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
NS grant. $429,000. PI: NAGI G AYAD
AI grant. $161,244. PI: TERESA GIL GIL
CA grant. $415,623. PI: STEPHEN J KADLECEK
AI grant. $267,000. PI: Qianxia Zhang
DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski
NR grant. $3,480,544. PI: Michelle Trivedi
ES grant. $795,869. PI: Sean M Harris
AI grant. $660,723. PI: Hongyan Guo
AI grant. $843,182. PI: Christopher F Basler
AT grant. $788,967. PI: ADAM L. Halberstadt
Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: QUAGEN. Form: SYRUP. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL
Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
AI grant. $209,758. PI: Paul K Drain
AT grant. $601,259. PI: Ashley E. Mason
NS grant. $568,920. PI: Theresa Currier Thomas
CA grant. $496,357. PI: DANIEL J BRAT
AT grant. $170,640. PI: Julia E. Hooker
AI grant. $210,302. PI: William Evan Johnson
DK grant. $231,000. PI: Roger D. Cone
NS grant. $230,562. PI: Thuy Nguyen
ES grant. $117,747. PI: Rebecca Sugrue
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Therapy area: Dermatology. Indication: Chronic Urticaria
No description on file. Bork keeps sniffing.
Sponsor: ACCORD HLTHCARE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.